2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP, 500 MG: new trials by email Literature Review of DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP, 500 MG trials Research Report on DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP, 500 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg DEPAKOTE® Tablets, 500 MG, DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP, 500 MG - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 17 | 2007-07-01 | 2010-08-18 |
| Fed Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg DEPAKOTE® Tablets, 500 MG, DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP, 500 MG - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 20 | 2007-07-01 | 2010-08-18 |
United States (2)